Article Text

Download PDFPDF
Blood sugar response to glucagon in migraine
  1. K. L. De Silva,
  2. M. A. Ron,
  3. John Pearce1
  1. Combined Neurological Service, Hull Royal Infirmary, Hull
  2. The Institute of Psychiatry, Maudsley Hospital, Denmark Hill, London


    The hyperglycaemic response to intramuscular glucagon was studied in 19 migraine subjects and 17 matched controls. Venous blood sugar 30 minutes after the injection, and the maximum rise from fasting levels, were significantly reduced in migraine subjects. This diminished sensitivity to the hyperglycaemic action of glucagon may be at least one factor in the hypoglycaemia unresponsiveness shown in migraine.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


    • 1 Requests for reprints: Dr. J. Pearce, Hull Royal Infirmary, Hull, 3 2J2.